Perspectives on ROCK2 as a Therapeutic Target for Alzheimer’s Disease
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cellular Neuroscience"
DOI: 10.3389/fncel.2021.636017
Abstract: Rho-associated coiled-coil containing kinase isoform 2 (ROCK2) is a member of the AGC family of serine/threonine kinases and an extensively studied regulator of actin-mediated cytoskeleton contractility. Over the past decade, new evidence has emerged that… read more here.
Keywords: rock2 therapeutic; perspectives rock2; alzheimer disease; disease ... See more keywords
The Immune System as a Therapeutic Target for Alzheimer’s Disease
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12091440
Abstract: Alzheimer’s disease (AD) is a heterogeneous neurodegenerative disorder and is the most common cause of dementia. Furthermore, aging is considered the most critical risk factor for AD. However, despite the vast amount of research and… read more here.
Keywords: therapeutic target; disease; alzheimer disease; system therapeutic ... See more keywords
Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16040580
Abstract: Alzheimer’s disease (AD) is the most common form of dementia. It increases the risk of other serious diseases and causes a huge impact on individuals, families, and socioeconomics. AD is a complex multifactorial disease, and… read more here.
Keywords: derived molecules; enzyme inhibitors; target alzheimer; inhibitors target ... See more keywords